| [1] |
Chen Z, Song X, Li Q, et al. Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer[J]. Cells, 2019, 8(8): 864.
|
| [2] |
Xiao H, Zhang F, Zou Y, et al. The Function and Mechanism of Long Non-coding RNA-ATB in Cancers[J]. Front Physiol, 2018, 9: 321.
|
| [3] |
Flippot R, Beinse G, Boilève A, et al. Long non-coding RNAs in genitourinary malignancies: a whole new world[J]. Nat Rev Urol, 2019, 16(8): 484-504.
|
| [4] |
Chandra GS, Nandan TY. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets[J]. Int J Cancer, 2017, 140(9): 1955-1967.
|
| [5] |
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1): 47-62.
|
| [6] |
Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes[J]. Cell, 2011, 147(4): 789-802.
|
| [7] |
Dykes IM, Emanueli C. Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA[J]. Genomics Proteomics Bioinformatics, 2017, 15(3): 177-186.
|
| [8] |
Bayat H, Narouie B, Ziaee S-AM, et al. Two long non-coding RNAs, Prcat17.3 and Prcat38, could efficiently discriminate benign prostate hyperplasia from prostate cancer[J]. Prostate, 2018, 78(11): 812-818.
|
| [9] |
Chistiakov DA, Myasoedova VA, Grechko AV, et al. New biomarkers for diagnosis and prognosis of localized prostate cancer[J]. Semin Cancer Biol, 2018, 52(Pt 1): 9-16.
|
| [10] |
张其强, 赵云丽, 张学宝, 等. PCA3基因在前列腺癌的诊断和治疗中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(3): 207-210.
|
| [11] |
Lemos AEG, Ferreira LB, Batoreu NM, et al. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells[J]. Tumour Biol, 2016, 37(8): 11339-11348.
|
| [12] |
Deng J, Tang J, Wang G, et al. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?[J]. Int J Environ Res Public Health, 2017, 14(3): 270.
|
| [13] |
Zhang Y, Pitchiaya S, Cieślik M, et al. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression[J]. Nat Genet, 2018, 50(6): 814-824.
|
| [14] |
Lin D. Commentary on "The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer." Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, MacDonald TY, Fontugne J, Erho N, Vergara IA, Ghadessi M, Davicioni E, Jenkins RB, Palanisamy N, Chen Z, Nakagawa S, Hirose T, Bander NH, Beltran H, Fox AH, Elemento O, Rubin MA, University of Washington-Urology, Seattle, WA. Nat Commun 2014; 5:5383[J]. Urol Oncol, 2016, 34(11): 522.
|
| [15] |
West JA, Davis CP, Sunwoo H, et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites[J]. Mol Cell, 2014, 55(5): 791-802.
|
| [16] |
Li X, Wang X, Song W, et al. Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit[J]. Cancer Res, 2018, 78(15): 4138-4149.
|
| [17] |
Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition[J]. Nature, 2014, 505(7483): 344-352.
|
| [18] |
Wu X, Xiao Y, Zhou Y, et al. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4[J]. Cell Death Dis, 2019, 10(7): 472.
|
| [19] |
Zhang G, He X, Ren C, et al. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1[J]. J Cell Physiol, 2019, 234(8): 13097-13109.
|
| [20] |
Xue D, Lu H, Xu HY, et al. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12[J]. J Cell Mol Med, 2018, 22(6): 3223-3237.
|
| [21] |
Guennewig B, Cooper AA. The central role of noncoding RNA in the brain[J]. Int Rev Neurobiol, 2014, 116: 153-194.
|
| [22] |
Gu P, Chen X, Xie R, et al. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer[J]. Mol Cancer, 2019, 18(1): 109.
|
| [23] |
Xiong T, Li J, Chen F, et al. PCAT-1: a novel oncogenic long non-coding RNA in human cancers[J]. Int J Biol Sci, 2019, 15(4): 847-856.
|
| [24] |
Prensner JR, Chen W, Iyer MK, et al. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer[J]. Cancer Res, 2014, 74(6): 1651-1660.
|
| [25] |
Prensner JR, Chen W, Han S, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc[J]. Neoplasia, 2014, 16(11): 900-908.
|
| [26] |
Shang Z, Yu J, Sun L, et al. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex[J]. Nucleic Acids Res, 2019, 47(8): 4211-4225.
|
| [27] |
Gu P, Chen X, Xie R, et al. lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5[J]. Mol Ther, 2017, 25(8): 1959-1973.
|
| [28] |
Ta HQ, Whitworth H, Yin Y, et al. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth[J]. Mol Cancer, 2019, 18(1): 113.
|
| [29] |
Liu D-C, Song L-L, Liang Q, et al. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression[J]. J Cell Physiol, 2019, 234(8): 12727-12744.
|
| [30] |
Luo J, Wang K, Yeh S, et al. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling[J]. Nat Commun, 2019, 10(1): 2571.
|
| [31] |
Sun T, Du S-Y, Armenia J, et al. Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer[J]. Oncogenesis, 2018, 7(3): 30.
|
| [32] |
Hua JT, Ahmed M, Guo H, et al. Risk SNP-Mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19[J]. Cell, 2018, 174(3): 564-575.
|
| [33] |
Qin F, Zhang Y, Liu J, et al. SLC45A3-ELK4 functions as a long non-coding chimeric RNA[J]. Cancer letters, 2017, 404: 53-61.
|
| [34] |
Su W, Xu M, Chen X, et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer[J]. Mol Cancer, 2017, 16(1): 142.
|
| [35] |
Wu M, Huang Y, Chen T, et al. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis[J]. J Cell Mol Med, 2019, 23(1): 29-38.
|